67-year-old man undergoes rare jaw tumour surgery in Chennai

A 67-year-old man in Chennai undergoes surgery for rare jaw tumours, restoring his breathing and swallowing abilities.

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

Dr. Hong’s longstanding commitment to innovation and compassion for his patients made him a pioneer in bringing the TULSA Procedure, a clinically proven, advanced prostate disease treatment, to ...

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, ...
The Manila Times

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East ...

Profound Medical Corp.: Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO to Australia and New Zealand

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered ...

Profound Medical Corp.: Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems in Saudi Arabia

Agreement creates runway for Profound's incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East All required regul ...